CONNOR PAULEY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family EXETER, NH NPI 1144707167

General Payments — all program years on this page

$891.35

  • Category: General Payments
  • Program years: PY2021–2023
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $315.44 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $297.1717
Education $18.272

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $83.955
2022 $491.9625
2023 $315.4419

Records — PY2023 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1011423547 AstraZeneca Pharmaceuticals LP $11.56 04/24/2023 Education Undisputed 01/23/2026 View at CMS
1011559298 AstraZeneca Pharmaceuticals LP $15.62 05/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014327865 AstraZeneca Pharmaceuticals LP $11.96 04/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014387717 AstraZeneca Pharmaceuticals LP $21.23 02/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014534009 AstraZeneca Pharmaceuticals LP $6.71 04/24/2023 Education Undisputed 01/23/2026 View at CMS
1014609565 AstraZeneca Pharmaceuticals LP $19.59 02/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014790977 AstraZeneca Pharmaceuticals LP $15.70 03/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014831265 AstraZeneca Pharmaceuticals LP $17.54 04/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015095299 AstraZeneca Pharmaceuticals LP $17.55 05/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015308089 AstraZeneca Pharmaceuticals LP $14.07 01/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015913257 AstraZeneca Pharmaceuticals LP $21.94 02/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015984441 AstraZeneca Pharmaceuticals LP $16.49 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1016260543 AstraZeneca Pharmaceuticals LP $17.04 04/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1027485703 Exact Sciences Corporation $13.74 03/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032789969 Lilly USA, LLC $17.86 03/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032865759 Lilly USA, LLC $12.72 05/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048527411 Merck Sharp & Dohme LLC $24.13 03/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049734498 PFIZER INC. $26.58 04/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996500771 Boehringer Ingelheim Pharmaceuticals, Inc. $13.41 04/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.